Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

• Published in: Journal of the International AIDS Society Vol. 13; no. S4; p. O51
• Main Authors: Eron, J, Livrozet, JM, Morlat, P, Lazzarin, A, Katlama, C, Hawkins, T, Fujiwara, T, Cuffe, R, Vavro, C, Santiago, J, Ait‐Khaled, M, Min, S, Yeo, JM
• Format: Journal Article
• Language: English
• Published: Geneva The International AIDS Society 01.11.2010; John Wiley & Sons, Inc; BioMed Central Ltd
• Subjects: Analysis; Antiretroviral drugs; Antiviral agents; Disease susceptibility; Dosage and administration; HIV infection; HIV testing; Human immunodeficiency virus; Integrase inhibitors; Oral Presentation; Prevention; Risk factors; Testing; Switzerland

7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK